Lugar de publicación
- Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study 2020
- Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination . 219:41-49. 2019
- Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections. 213:939-947. 2015
- Pathogenic Brucellae Replicate in Human Trophoblasts. 207:1-9. 2013
- Reactive Oxygen Species and the MEK/ERK Pathway Are Involved in the Toxicity of Clostridium perfringens -Toxin, a Prototype Bacterial Phospholipase C. 206:1218-1226. 2012
- Increased infectivity of Staphylococcus aureus in an experimental model of snake venom-induced tissue damage. 196:748-754. 2007